Skip to content
  • Sunday, 26 July 2026
  • 2:56 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The $1.8 Billion Telehealth Conundrum: Medvi’s Rise Amidst Regulatory Gaps, AI Deception, and the Compounded Drug Market
Laboratory Automation & Robotics

The $1.8 Billion Telehealth Conundrum: Medvi’s Rise Amidst Regulatory Gaps, AI Deception, and the Compounded Drug Market

Lana Keisha Jun 1, 2026 0

A recent profile by The New York Times celebrated Medvi, a burgeoning telehealth enterprise, as a testament to the transformative…

Read More
Laboratory Automation & Robotics

Medvi: The $1.8 Billion Telehealth Company Built on Regulatory Gaps, Fake Testimonials, and AI Deception

Lana Keisha May 9, 2026 0

A recent profile by The New York Times lauded Medvi as a prime example of artificial intelligence’s potential to empower…

Read More
Laboratory Automation & Robotics

MEDVi: The AI-Powered Telehealth Startup Under Fire Amidst FDA Warnings, Deception Allegations, and Mounting Lawsuits

Lana Keisha Apr 18, 2026 0

In an era increasingly shaped by artificial intelligence, the promise of rapidly scalable, AI-driven enterprises has captivated the global imagination.…

Read More
The Universe as a Cosmic Ledger: New Quantum Memory Matrix Theory Challenges Foundations of Physics and CosmologyInsuring the trip: an underwriter on what it will take for approved psilocybin can become a real businessStanford Researchers Develop Breakthrough Bio-Inspired Material Capable of Real-Time Texture and Color TransformationInternalized Stress and Feelings of Hopelessness Linked to Accelerated Memory Decline in Older Chinese Americans according to Rutgers Research
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ